122 related articles for article (PubMed ID: 34544027)
1. Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy.
Yue K; Hou X; Jia G; Zhang L; Zhang J; Tan L; Wang X; Zhang Z; Li P; Xu W; Li X; Jiang Y
Bioorg Chem; 2021 Nov; 116():105343. PubMed ID: 34544027
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
[TBL] [Abstract][Full Text] [Related]
3. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.
Jiang Y; Hou J; Li X; Huang Y; Wang X; Wu J; Zhang J; Xu W; Zhang Y
Bioorg Med Chem; 2016 Nov; 24(22):5787-5795. PubMed ID: 27670098
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
7. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
[TBL] [Abstract][Full Text] [Related]
8. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
9. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Toshiyama R; Konno M; Eguchi H; Takemoto H; Noda T; Asai A; Koseki J; Haraguchi N; Ueda Y; Matsushita K; Asukai K; Ohashi T; Iwagami Y; Yamada D; Sakai D; Asaoka T; Kudo T; Kawamoto K; Gotoh K; Kobayashi S; Satoh T; Doki Y; Nishiyama N; Mori M; Ishii H
Oncogene; 2019 Jan; 38(2):244-260. PubMed ID: 30089817
[TBL] [Abstract][Full Text] [Related]
10. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.
Chen X; Liu Y; Zhang L; Chen D; Dong Z; Zhao C; Liu Z; Xia Q; Wu J; Chen Y; Zheng X; Cai Y
Eur J Med Chem; 2021 Mar; 214():113219. PubMed ID: 33618175
[TBL] [Abstract][Full Text] [Related]
13. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
15. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy.
Ma X; Cheng Z; Jin Y; Liang X; Yang X; Dai Z; Tian J
Biomaterials; 2014 Mar; 35(9):2878-89. PubMed ID: 24411331
[TBL] [Abstract][Full Text] [Related]
16. β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma.
Ling Y; Gao WJ; Ling C; Liu J; Meng C; Qian J; Liu S; Gan H; Wu H; Tao J; Dai H; Zhang Y
Eur J Med Chem; 2019 Apr; 168():515-526. PubMed ID: 30851694
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids.
Deng X; Luo T; Li Z; Wen H; Zhang H; Yang X; Lei F; Liu D; Shi T; Zhao Q; Wang Z
Eur J Med Chem; 2022 Jan; 228():113985. PubMed ID: 34802836
[TBL] [Abstract][Full Text] [Related]
18. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture.
Cui J; Nan KJ; Tian T; Guo YH; Zhao N; Wang L
World J Gastroenterol; 2007 Nov; 13(41):5432-9. PubMed ID: 17907285
[TBL] [Abstract][Full Text] [Related]
19. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
